The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA)
for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products"
for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive
list of drugs or products used to treat this condition. There may be other products available that are not considered
orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat
other conditions by searching the Orphan Drug Product Designation database.
The FDA has approved this product to be used in this manner.
Management of neuropathic pain associated with postherpetic neuralgia
|More Information about this product
Drug Information Portal